|
03.01.2010
Genetic background of metabolic disturbances revealed +++ Stem cell chip highlights brain damage +++ 37 million euros for Protein Research Centre in Bochum +++ 70 million euros for research excellence in East Germany +++ Curetis AG brings in 18.5 million euros
|
|
02.09.2009
One cell suffices for human stem cells +++ Green genetic engineering swirls up election campaign +++ Qiagen in 30 million-euro expansion in Hilden +++ Green genetic engineering: Politics promotes "No GM"; Industry wants the opposite +++ Success and disappointment with generic biotech drugs +++ Drug resistant fish provide genetic set for anti-addictive +++ 57 million euros for Munich catalysis centre
|
|
03.08.2009
Micromet pulls in 50 million euros on the money market +++ Colorectal cancer: Genetic fingerprint for metastasis identified +++ Independent development for versatile testicular stem cells +++ German Federal states invest millions in biotechnology +++ EMEA halts the march of Merck's Erbitux +++ Target for new antibiotics discovered
|
|
03.07.2009
Gentler treatment for autoimmune diseases +++ Helmholtz Association: 20 million for BioInterface program +++ Preventing organ transplant rejection +++ New tools for tuberculosis vaccine +++ Swine flu detection without symptoms +++ Wallets out for BioNTech in Mainz +++ GPC changes into Agennix
|
|
04.06.2009
New blood test for Alzheimer’s diagnosis +++ Tears substance finds use as cancer therapy tool +++ Therapeutic effect in inflammatory nerve diseases decrypted +++ Sanofi-Aventis to invest 63 million euros in Frankfurt +++ German biotech branch growing despite crisis +++ Resistance mechanism explained for ovarian cancer therapy +++
|
|
04.05.2009
Bayer CropScience pulls agrobiotechnology out of Potsdam +++ Repairing the heart using stem cells +++ Economic stimulus package for biotechnology +++ Red biotechnology: growing and growing +++ Probiotic foods halt intestinal inflammation +++ German Parliament adopts Gene Diagnosis Law
|
|
02.03.2009
GPC find merger partners +++ Qiagen to invest in the location Germany +++ New genes discovered for cardiac infarction +++ New EMEA Committee under German leadership +++ Atherosclerosis as a malfunction of the body’s own immune system +++ On the hunt for asthma genes
|
|
02.02.2009
Bioeconomy council begins work +++ Pigs in sight as organ donors +++ Qiagen heads EU-funded project on sample standards +++ Wilex and UCB exchange money and know-how +++ Enzyme detective discovers virus genome +++ Epilepsy apparently caused by gaps in the chromosome
|
|
31.12.2008
Transgenic stem cells implanted in the brain +++ MPI researchers develop free computer program for protein analysis +++ Prosecutor investigating against stem cell researcher +++ 2009 to be a difficult year +++ Profos AG goes bankrupt +++ Evotec boss quits +++ European Food Safety Authority opinion on Amflora delayed +++ GM soya import allowed
|
|
28.11.2008
Pfizer shuts down production +++ Sygnis pulls in seven-figure funds +++ CIA invests in Germany +++ Record investment in Ganymed +++ Research may be distorted by plastic vessels +++ Cause of premature aging identified +++ Reducing pain without dulling the mind +++ Fat-reducing substance against Alzheimer's +++ Stem cell patent rejected
|
